Literature DB >> 5953457

Amino-glutethimide and metastatic adrenal cancer. Maintained reversal (six months) of Cushing's syndrome.

D E Schteingart, R Cash, J W Conn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5953457

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

Review 1.  Current perspective in the diagnosis and treatment of adrenocortical carcinoma.

Authors:  D E Schteingart
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Changes in the fine structure and function of a hormone-secreting adrenocortical tumour investigated in tissue culture.

Authors:  D Szabó; A Gyévai; E Gláz; E Stark; M Péteri; O Alánt
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975-09-18

Review 3.  Aminoglutethimide: a "side-effect" turned to therapeutic advantage.

Authors:  S W Hughss; D M Burley
Journal:  Postgrad Med J       Date:  1970-07       Impact factor: 2.401

4.  Fluctuating Cushing's syndrome, acute psychosis, aminoglutethimide therapy.

Authors:  I G Barnett; J D Nabarro; L P LeQuesne
Journal:  Proc R Soc Med       Date:  1970-04

5.  Management of acute hypercortisolism.

Authors:  N W Thompson; M D Allo
Journal:  World J Surg       Date:  1982-11       Impact factor: 3.352

Review 6.  Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.

Authors:  P E Lønning; S Kvinnsland
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

7.  Abnormal regulation of adenosine 3',5'-monophosphate and corticosterone formation in an adrenocortical carcinoma.

Authors:  R L Ney; N J Hochella; D G Grahame-Smith; R N Dexter; R W Butcher
Journal:  J Clin Invest       Date:  1969-09       Impact factor: 14.808

8.  The evolution of treatment for early breast cancer: what's next?

Authors:  T Howell
Journal:  Ecancermedicalscience       Date:  2009-06-09

Review 9.  Systemic therapy of Cushing's syndrome.

Authors:  Niels Eckstein; Bodo Haas; Moritz David Sebastian Hass; Vladlena Pfeifer
Journal:  Orphanet J Rare Dis       Date:  2014-08-05       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.